Clinical trialNCT06646445Not, yet, recruitingPhase 2Interventional

Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.

SponsorGERCOR - Multidisciplinary Oncology Cooperative GroupEnrollment60Colon Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France

Institut Sainte Catherine
Avignon, France
Clémence TOULLEC
Chu Besançon
Besançon, France
Angélique VIENOT
Ihfb Cognacq Jay
Levallois-Perret, France
Benoist CHIBAUDEL
Centre Leon Berard
Lyon, France
Groupe Hospitalier Diaconesses Croix Saint Simon
Paris, France
Olivier DUBREUIL
Hôpital Saint Antoine
Paris, France
Romain Cohen
Institut Mutualiste Montsouris
Paris, France
Raphaël COLLE
Chu Bordeaux Haut Lévêque
Pessac, France
Eric TERREBONNE
Chu Poitiers
Poitiers, France
Chu Toulouse
Toulouse, France
Rosine GUIMBAUD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2025
Primary completion: 31 Dec 2027
Completion: 31 Dec 2029
Last update posted: 13 Jun 2025
Registered enrollment: 60
Registry id: NCT06646445

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.